Greene John
CIK 0001610732
EVP, Chief Financial OfficerDirector
Filings
19
Latest Feb 13, 2026
Issuers covered
3
Showing
19 of 19
Page 1
Track record
1 of 3 open-market trades scored (33% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -16.7% | -16.7% | -16.7% | -16.7% |
| 90 days | 1 | 0% | -15.4% | -15.4% | -15.4% | -15.4% |
| 180 days | 1 | 100% | +21.9% | +21.9% | +21.9% | +21.9% |
| 365 days | 1 | 100% | +39.1% | +39.1% | +39.1% | +39.1% |
Issuers
Companies where Greene John has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DFS | Discover Financial Services | 13 | May 19, 2025 |
| CRSP | Crispr Therapeutics AG | 5 | Jun 6, 2025 |
| NOC | Northrop Grumman Corp /De/ | 1 | Feb 13, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|